12:00 AM
 | 
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Pfizer, Alliance for Lupus Research (ALR) deal

The Alliance partnered with Pfizer to discover therapies to treat lupus under the pharma's Global Centers for Therapeutic Innovation initiative. The partners will co-fund translational research, which is slated to begin next...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >